Synapsoft logo
AI Insights from Disclosures
Searching...
DAEWOONG PHARMA 069620
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
DAEWOONG PHARMA was established on October 2, 2002, through a spin-off, as of the reference date of October 1, 2002, of a business division of Daewoong Co., Ltd. (whose name before the split was Daewoong Pharmaceutical Co., Ltd.), and engages in the manufacture and sale of pharmaceuticals as its main business. The company listed on the securities market opened by the Korea Exchange (formerly the Korea Stock & Futures Exchange) on November 1, 2002, and as of the end of the reporting period operates manufacturing facilities that meet KGMP standards for pharmaceutical production at the Hyangnam Industrial Complex in Hwaseong and at the Osong plant.
Representative Director Lee Changjae, Park Seongsu
Founded October 1, 2002
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 13481-0075342
Business number 124-86-01143
Phone Number 02-550-8800
Fax Number 02-2059-1690
Company Address 35-14 Jeyakgongdan 4-gil, Hyangnam-eup, Manse-gu, Hwaseong-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant